International Journal of Tuberculosis and Lung Disease

Top Research Topics at International Journal of Tuberculosis and Lung Disease?

International Journal of Tuberculosis and Lung Disease covers a variety of subjects, including Tuberculosis, Internal medicine, Gynecology, Surgery and Mycobacterium tuberculosis. In particular, the Tuberculosis works presented emphasize discussions on Sputum. In International Journal of Tuberculosis and Lung Disease, Gastroenterology and Isoniazid are investigated in conjunction with one another to address concerns in Internal medicine research.

The Gynecology research presented in the journal explores the relationship between Lung disease and the closely related topic of Pulmonary tuberculosis. The studies tackled, which mainly focus on Surgery, apply to Antibacterial agent as well. The concepts on Mycobacterium tuberculosis presented in it can also apply to other research fields, including Rifampicin, Virology, Drug resistance, Microbiology and Molecular biology.

International Journal of Tuberculosis and Lung Disease holds forums on MEDLINE that merges themes from other disciplines such as Family medicine and Intensive care medicine. The study on Incidence (epidemiology) presented in it intersects with subjects under the field of Epidemiology. While work presented in International Journal of Tuberculosis and Lung Disease provided substantial information on Epidemiology, it also covered topics in Public health and Environmental health.

• Tuberculosis (53.19%)
• Internal medicine (19.55%)
• Gynecology (17.92%)

What are the most cited papers published in the journal?

• The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. (543 citations)
• The curious characteristics of pyrazinamide: a review. (504 citations)
• False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? (503 citations)

Research areas of the most cited articles at International Journal of Tuberculosis and Lung Disease:

The main points discussed in the most cited publications deal with Tuberculosis, Gynecology, Surgery, Internal medicine and Mycobacterium tuberculosis. The journal papers feature studies on Tuberculosis, including topics such as Sputum. Aside from discussions in Gynecology, the published papers also deal with the subject of Lung disease which intersects with Pulmonary tuberculosis disciplines.

What topics the last edition of the journal is best known for?

• Internal medicine
• Disease
• Diabetes mellitus

The previous edition focused in particular on these issues:

International Journal of Tuberculosis and Lung Disease focuses on Internal medicine, MEDLINE, Coronavirus disease 2019 (COVID-19), Tuberculosis and Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The journal explores issues in Internal medicine which can be linked to other research areas like Multidrug-Resistant TB and Tb treatment. Issues in MEDLINE were discussed, taking into consideration concepts from other disciplines like Family medicine and Intensive care medicine.

The research on Coronavirus disease 2019 (COVID-19) discussed in International Journal of Tuberculosis and Lung Disease draws on the closely related field of Coinfection. It explores topics in Tuberculosis which can be helpful for research in disciplines like Drug resistance and Environmental health. International Journal of Tuberculosis and Lung Disease connects research in Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with the related topic of 2019-20 coronavirus outbreak.

The most cited articles from the last journal are:

• TB and COVID-19 co-infection: rationale and aims of a global study. (11 citations)
• The impact of COVID-19 on TB: a review of the data (8 citations)
• Mortality due to TB-COVID-19 coinfection in India. (6 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in International Journal of Tuberculosis and Lung Disease (based on the number of publications) are:

• Anthony D. Harries (117 papers) published 2 papers at the last edition, 5 less than at the previous edition,
• Donald A. Enarson (111 papers) absent at the last edition,
• Felix M Salaniponi (63 papers) absent at the last edition,
• Anneke C. Hesseling (61 papers) published 2 papers at the last edition, 2 less than at the previous edition,
• A. Van Deun (60 papers) published 3 papers at the last edition the same number as at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in International Journal of Tuberculosis and Lung Disease (based on the number of publications) are:

• Centers for Disease Control and Prevention (289 papers) published 4 papers at the last edition, 7 less than at the previous edition,
• International Union Against Tuberculosis and Lung Disease (281 papers) published 7 papers at the last edition, 28 less than at the previous edition,
• World Health Organization (229 papers) published 9 papers at the last edition, 16 less than at the previous edition,
• Johns Hopkins University (211 papers) published 13 papers at the last edition, 1 less than at the previous edition,
• University of Cape Town (210 papers) published 12 papers at the last edition, 4 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 11.79% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 33.72% were posted by at least one author from the top 10 institutions publishing in the journal. Another 9.30% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 21.51% of all publications and 35.47% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities and Progression in Tuberculosis and Lung Disease Research

While discussing the myriad of research opportunities in the field of Tuberculosis and Lung Disease, it is crucial to also touch upon the career progression and educational requirements for professionals in this field. As this area is multidisciplinary, it involves professionals from various backgrounds like internal medicine, gynecology, surgery, and molecular biology, to name a few.

One such professional is a nurse practitioner, who often plays a pivotal role in this area of research and healthcare. In the state of New Mexico, for instance, a nurse practitioner requires meeting certain educational, certification, and training prerequisites to be eligible to practice. Read more about the nurse practitioner education requirements in New Mexico on our dedicated career resource page.

Overall, research careers in the field of Tuberculosis and Lung Disease are intellectually stimulating and rewarding, albeit challenging. The opportunities for progression are abundant, given this field's ever-evolving nature and its importance in the realms of public health and global disease eradication.